Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bruggmann

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|June 4, 2013
Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugsPhilip Bruggmann
Praxis|March 31, 2017
Gaps in Hepatitis C Care of People Who Use DrugsPhilip Bruggmann
Swiss Medical Weekly|April 3, 2023
Eliminating viral hepatitis B and C in times of war and increasing global refugee crisisPhilip Bruggmann
Praxis|July 28, 2016
[Not Available]Philip Bruggmann
Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi|August 9, 2021
Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve EliminationNathalie Brunner, Philip Bruggmann
Swiss Medical Weekly|October 9, 2020
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruitPhilip Bruggmann, Bettina Maeschli
The International Journal on Drug Policy|September 24, 2014
Prevention, treatment and care of hepatitis C virus infection among people who inject drugsPhilip Bruggmann, Jason Grebely
European Journal of Public Health|July 26, 2014
Birth year distribution in reported hepatitis C cases in SwitzerlandPhilip Bruggmann, Jean-Luc Richard,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit allPhilip Bruggmann, Alain H Litwin
Health Policy (Amsterdam, Netherlands)|May 27, 2019
The Swiss Hepatitis Strategy as a model for facing future health policy challengesRaoul Blindenbacher, Bettina Maeschli, Philip Bruggmann
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|June 4, 2013
Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugsPhilip Bruggmann
Praxis|March 31, 2017
Gaps in Hepatitis C Care of People Who Use DrugsPhilip Bruggmann
Swiss Medical Weekly|April 3, 2023
Eliminating viral hepatitis B and C in times of war and increasing global refugee crisisPhilip Bruggmann
Praxis|July 28, 2016
[Not Available]Philip Bruggmann
Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi|August 9, 2021
Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve EliminationNathalie Brunner, Philip Bruggmann
Swiss Medical Weekly|October 9, 2020
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruitPhilip Bruggmann, Bettina Maeschli
The International Journal on Drug Policy|September 24, 2014
Prevention, treatment and care of hepatitis C virus infection among people who inject drugsPhilip Bruggmann, Jason Grebely
European Journal of Public Health|July 26, 2014
Birth year distribution in reported hepatitis C cases in SwitzerlandPhilip Bruggmann, Jean-Luc Richard,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit allPhilip Bruggmann, Alain H Litwin
Health Policy (Amsterdam, Netherlands)|May 27, 2019
The Swiss Hepatitis Strategy as a model for facing future health policy challengesRaoul Blindenbacher, Bettina Maeschli, Philip Bruggmann
Pageof 9